Impact of Tumor Size on Long-Term Survival of Patients with Organ-Confined Renal Cell Cancer;Welche Tumorgröße korreliert am besten mit dem Progressionsrisiko lokal organbegrenzter Nierenzellkarzinome?

Aktuelle Urologie

Volumn 34, Issue 7, 2003, Pages 469-474

  Merseburger, A S ^a,c   Wegener, G ^b   Horstmann, M ^a   Oelke, M ^b   Zumbragel A ^a   Bokemeyer, C ^a   Kollmannsberger, C ^a   Jonas, U ^b   Stenzl, A ^a   Kuczyk, M ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Organ confined; Prognosis; Renal cancer; Stage; Tumor size

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DEATH; DISEASE COURSE; FEMALE; HIGH RISK PATIENT; HUMAN; KIDNEY CAPSULE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEPHRECTOMY; PROGNOSIS; RISK ASSESSMENT; STATISTICAL ANALYSIS; SURVIVAL TIME; TUMOR LOCALIZATION; TUMOR VOLUME; AGE; ANALYSIS OF VARIANCE; COMPARATIVE STUDY; KIDNEY; KIDNEY TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEPHRECTOMY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT;

EID: 0347993679     PISSN: 00017868     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-45267     Document Type: Article

References (21)

1. Sobin LH, Wittekind CH. TNM classification of malignant tumours. 5th ed. New York: Wiley-Liss, 1997
2. Wittekind Ch, Meyer H-J, Bootz F. TNM-Klassifikation maligner Tumoren. 6th ed. Berlin, Heidelberg, New York, Barcelona: Springer-Verlag, 2002
3. Javidan J, Stricker HJ, Tamboli P, Amin MB, Peabody JO, Deshpande A, Menon M, Amin MB. Prognostic significance of the 1997 TNM classification of renal carcinoma. J Urol 1999; 162: 1277-1281
4. Minervini R, Minervini A, Fontana N, Traversi C, Cristofani R. Evaluation of the 1997 tumour, nodes and metastases classification of renal cell carcinoma: experience in 172 patients. Br Urol 2000; 86: 199-202
5. Guinan P, Sobin LH, Algaba F, Badellino F, Kameyama S, MacLennan G, Novick A. TNM staging of renal cell carcinoma. Workgroup No 3. Cancer 1997; 80: 992-993
6. Hafez KS, Fergany AF, Novick AC. Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging. J Urol 1999; 162: 1930-1933
7. Licht M, Novick AC, Goormastic M. Nephron sparing surgery in incidental vs. suspected renal cell carcinoma. J Urol 1994; 152: 39-43
8. Lerner SE, Hawkins CA, Blute ML, Grabner A, Wollan PC, Eickholt JT, Zincke H. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery. J Urol 1996; 155: 1868-1873
9. Shinohara N, Harabayashi J, Koyanagi T. Stage - specific follow up protocol after radical nephrectomy for renal cell carcinoma: could we follow the T1B patients by a same follow up protocol of T1A patients? (Abstract 662). J Urol 2001; 165 (suppl.): 161
10. Gettman MT, Blute ML, Spotts B, Bryant SC, Zincke H. Pathologic staging of renal cell carcinoma. Significance of tumor classification with the 1997 staging system. Cancer 2001; 91: 354-361
11. Krejci KG, Frank I, Blute ML. Grade - and size - specific outcomes for stage T1 renal cell carcinoma (RCC) after nephron sparing surgery (NSS). (Abstract 651). J Urol 2001; (suppl.): 158
12. Zisman A, Pantuck AJ, Chao D, Dorey F, Said JW, Gitlitz BJ, Kernion JB de, Figlin RA, Belldegrun AS. Reevaluation of the 1997 TNM classification for renal cell carcinoma: T1 and T2 cutoff point at 4.5 cm rather than 7 cm better correlates with clinical outcome. J Urol 2001; 166: 54-58
13. Slaton JW, Levy DA, Perrotte P et al. Practical application of renal cell carcinoma prognostic factors to a risk factor driven approach to tumor surveillance after radical nephrectomy. (Abstract 659). J Urol 2001; 165 (suppl.): 160
14. Delahunt B, Kittelson JM, McCredie MR, Reeve AE, Stewart JH, Bilous AM. Prognostic importance of tumor size for localized conventional (clear cell) renal cell carcinoma. Cancer 2002; 94: 658-664
15. Walker JR, Choyke PL, Glenn G et al. Association of renal tumor size and metastasis in four different hereditary renal tumor syndromes. (Abstract 656). J Urol 2001; (suppl.): 160-
16. Delahunt B, Eble JN. Papillary adenoma of the kidney: an evolving concept. J Pathol 1997; 7: 99-112
17. Baltaci S, Orhan D, Soyupek S et al. Influence of tumor stage, size, grade, vascular involvement, histological cell type and histological pattern on multifocality of renal cell carcinoma. J Urol 2000; 164: 36-39
18. Turner KJ, Huson SM, Moore N, Britton BJ, Cranston D. Von Hippel-Lindau disease: renal tumors less than 3 cm can metastasize. J Urol 2001; 165: 1207
19. Elmore JM, Kadesky KT, Koeneman KS, Sagalowsky AL. Reassessing the 1997 TNM classification system for renal cell carcinoma: a 5.0 cm T1/T2 cut-off better stratifies clinical outcome. (Abstract 783). J Urol 2002; 167 (suppl.): 194
20. Miller J, Fischer C, Freese R, Altmannsberger M, Weidner W. Nephron-sparing surgery for renal cell carcinoma: is tumor size a suitable parameter for indication. Urology 1999; 54: 988-993
21. Kuczyk M, Münch T, Machtens S, Bokemeyer C, Wefer A, Hartmann J, Kollmannsberger C, Kondo M, Jonas U. The need for routine adrenalectomy during surgical treatment for renal cell cancer: the Hannover experience. BJU Int 2002; 89: 517-522